Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
J Vet Med A Physiol Pathol Clin Med ; 51(1): 15-8, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15086505

ABSTRACT

The nomenclature of ulcerative dermatitis as used in literature is somehow confusing because on the one hand this skin disorder is associated with bacterial growth and on the other hand it is a synonym for a chronic sporadic disease of adult sows with unknown aetiology. Thus, we propose the terminus 'Porcine Ulcerative Dermatitis Syndrome (PUDS)' for the latter to distinguish between these two disease complexes. This syndrome could be identified by clinical and pathological examinations in six sows, that were submitted to the clinic. Epidermal ulcers could be found nearly all over the body, but teats were always spared. Haematological examination showed a slight anaemia but physiological leucocyte counts. However, lymphopenia (x = 44.8%), granulocytosis (x = 42.0%) and an increased number of monocytes (x = 13.1%) could be found. Histologically, a lymphoplasmacytic and granulohistiocytic infiltration in the corium was most prominent. In some cases, a moderate leucocytoclastic vasculitis and perivasculitis could be seen at the dermo-epidermal border. Additionally, a multifocal interstitial nephritis with lymphoplasmacytic infiltration was a prominent feature in all animals. Participation of an immune complex associated disorder can be assumed when regarding histological findings as skin lesions in combination with glomerulonephritis are a common feature of such diseases. Also, IgG levels were elevated two- to fourfold in all affected sows when compared with healthy control pigs. This supports the hypothesis that not only T cells, as shown previously, but also the humoral branch of the immune system is involved in the aetiology of PUDS.


Subject(s)
Dermatitis/veterinary , Skin Ulcer/veterinary , Swine Diseases/pathology , Animals , Blood Chemical Analysis/veterinary , Dermatitis/pathology , Female , Hypergammaglobulinemia/blood , Hypergammaglobulinemia/veterinary , Immunoglobulin G/blood , Pregnancy , Pregnancy Complications/pathology , Pregnancy Complications/veterinary , Skin Ulcer/pathology , Swine , Swine Diseases/blood , Syndrome
2.
J Biotechnol ; 44(1-3): 161-70, 1996 Jan 26.
Article in English | MEDLINE | ID: mdl-8717400

ABSTRACT

Expression of cloned PhiX174 gene E in bacteria results in lysis of bacteria. It is unique among phage lysis systems as it introduces a transmembrane tunnel structure through the cell envelope complex of Gram-negative bacteria. The resulting bacterial ghosts have intact envelope structures devoid of cytoplasmic contents. E-mediated lysis has been achieved in a variety of Gram-negative bacteria including Escherichia coli, Salmonella typhimurium, Vibrio cholerae, Klebsiella pneumoniae, and Actinobacillus pleuropneumoniae. Such ghosts, derived from human or animal pathogens, have been proposed as non-living candidate vaccines and represent an alternative to heat or chemically inactivated bacteria. In 'recombinant ghosts', foreign proteins (e.g., viral proteins) are inserted into the inner membrane via specific N-, or C-, or N- and C-terminal anchor sequences prior to lysis. Relevant advantages of (recombinant) bacterial ghosts as immunogens include: (i) inactivation procedures that denature relevant immunogenic determinants are not employed in the production of ghosts used as vaccines or as carriers of relevant antigens; (ii) the recombinant proteins are inserted into a highly immune stimulatory environment; (iii) there is no size limitation of the foreign protein moieties: multiple antigenic determinants can be presented simultaneously; (iv) bacterial ghosts can be produced inexpensively in large quantities; (v) (recombinant) ghosts are stable for long periods of time and do not require the cold chain storage system. Intraperitoneal, subcutaneous or intramuscular applications of recombinant ghosts in experimental animals induced specific humoral and cellular immune responses against bacterial and viral components. Initial aerosol vaccinations of swine with ghosts from Actinobacillus pleuropneumoniae showed that protective immunity can be established by this route of application and that the well-preserved surface structures of ghosts obtained by E-mediated lysis are able to target the mucosal immune system.


Subject(s)
Bacterial Vaccines , Cell Membrane/immunology , Gram-Negative Bacteria/immunology , Gram-Negative Bacterial Infections/immunology , Vaccines, Synthetic , Animals , Antibody Formation , Bacterial Vaccines/adverse effects , Bacteriophage phi X 174/genetics , Cloning, Molecular , Escherichia coli/immunology , Escherichia coli/ultrastructure , Genes, Viral , Gram-Negative Bacterial Infections/prevention & control , Gram-Negative Bacterial Infections/veterinary , Humans , Replication Origin , Vaccines, Synthetic/adverse effects
3.
J Biotechnol ; 44(1-3): 171-81, 1996 Jan 26.
Article in English | MEDLINE | ID: mdl-8717401

ABSTRACT

In order to outline basic concepts for the design of a bacterial aerosol infection model, the development of a pig model with Actinobacillus pleuropneumoniae is described. First, reproducibility of aerosol parameters should be maintained by optimizing generating and sampling conditions. Survival rates of the chosen strain must be predictable. Secondly, inhalation conditions for the recipients have to be standardized to enable the determination of deposition sites and the dose administered. Subsequently, dose-response relationship should be evaluated to find a suitable challenge dose. Furthermore, it seems necessary to establish methods to obtain local specimens for determination of the local immune responses. The present study demonstrates that after aerosol challenge pigs were completely protected after inhalation and partially protected after oral application of A. pleuropneumoniae vaccines and describes techniques to administer bacteria in a dose-dependent, viable way. Using the infection model several stages of the disease from acute pleuropneumonia to chronic infection can be induced for research purposes.


Subject(s)
Actinobacillus Infections/immunology , Actinobacillus Infections/veterinary , Actinobacillus pleuropneumoniae , Bacterial Vaccines/administration & dosage , Swine Diseases , Actinobacillus Infections/prevention & control , Actinobacillus pleuropneumoniae/immunology , Administration, Inhalation , Administration, Oral , Aerosols , Animals , Bronchoalveolar Lavage Fluid , Dose-Response Relationship, Drug , Humans , Immunization Schedule , Lymphocytes/immunology , Reproducibility of Results , Swine
4.
Infect Immun ; 63(7): 2797-800, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7790104

ABSTRACT

The gene encoding an outer membrane lipoprotein (omlA) of Actinobacillus pleuropneumoniae serotype 5 was cloned, and the protein was expressed in Escherichia coli. One open reading frame of 1,104 bp was detected that encoded a protein (OmlA) with a predicted molecular mass of 40 kDa. A comparison with the omlA gene and the corresponding protein of A. pleuropneumoniae serotype 1 (G.-F. Gerlach, C. Anderson, S. Klashinsky, A. Rossi-Kampos, A.A. Potter, and P.J. Wilson, Infect. Immun. 61:565-572, 1993) revealed that the nucleic acid sequences had an overall sequence identity of 62.9% and the deduced amino acid sequences showed a sequence agreement of 57.3%. Both proteins were antigenically distinct. In a Western blot (immunoblot) analysis using a specific antiserum against A. pleuropneumoniae serotype 5 OmlA, a homologous protein was detected in the reference strains of A. pleuropneumoniae serotypes 5A, 5B, and 10. Pigs immunized with this recombinant protein were protected from death in an aerosol challenge experiment with an A. pleuropneumoniae serotype 5 isolate.


Subject(s)
Actinobacillus Infections/prevention & control , Actinobacillus pleuropneumoniae/genetics , Bacterial Outer Membrane Proteins/genetics , Genes, Bacterial , Lipoproteins/genetics , Amino Acid Sequence , Animals , Bacterial Vaccines/immunology , Base Sequence , Cloning, Molecular , DNA, Bacterial/genetics , Female , Male , Molecular Sequence Data , Sequence Alignment , Sequence Homology, Amino Acid , Serotyping , Swine , Vaccines, Synthetic/immunology
5.
Vaccine ; 12(14): 1330-4, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7856300

ABSTRACT

The immunogenic potential of Vibrio cholerae ghosts (VCG) in comparison with heat-killed whole-cell vibrios (WCV) was evaluated after intraperitoneal immunization of adult mice. Swiss white mice received four doses of VCG or WCV intraperitoneally, consisting of 500 micrograms of lyophilized material in 200 microliters of phosphate-buffered saline (PBS), pH 7.4. The control group received 200 microliters of PBS. Serum samples were collected from all mice on the day of immunization and on days 14, 24, 35 and 62 postimmunization. Sera were examined for vibriocidal antibodies by the microtitre and tube-dilution methods and Vibrio-specific serum IgG antibodies were assessed by ELISA. IgG antibodies to intact WCV were detected in sera from all animals immunized with VCG or WCV. The response was specific and of high magnitude. Significantly higher antibody responses were obtained when sera from both VCG- and WCV-immunized mice were titrated against VCG. The immunogenicity of VCG in evoking serum IgG responses was higher than that of WCV. However, the immunogenicity of the two antigen preparations was comparable in terms of seroconversion for vibriocidal antibodies. These results demonstrate that VCG administered intraperitoneally evoke Vibrio-specific serum IgG responses as well as vibriocidal antibody activity in mice.


Subject(s)
Antibodies, Bacterial/biosynthesis , Bacterial Vaccines/immunology , Vibrio cholerae/immunology , Animals , Bacteriological Techniques , Enzyme-Linked Immunosorbent Assay , Injections, Intraperitoneal , Mice , Viral Proteins/immunology
6.
Clin Exp Immunol ; 96(1): 91-7, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8149673

ABSTRACT

To investigate the antibody response after local application of lung-pathogenic bacteria, pigs were immunized with viable or inactivated Actinobacillus pleuropneumoniae by the oral and aerogenous route. After 3 weeks class-specific immunoglobulins against purified A. pleuropneumoniae capsular polysaccharides (CP) were determined in serum and BALF by ELISA. A significant increase of IgA antibodies was found in BALF but not in sera of all immunized pigs. Oral immunization with viable A. pleuropneumoniae and aerosol immunization with either viable or inactivated bacteria resulted in a significant increase of IgG antibodies to the CP antigen in BALF, whereas only aerosol exposure to viable bacteria resulted in a significant increase in IgG antibodies in serum. A significant increase in anti-CP IgM in BALF was observed after aerosol exposure but not after oral immunization. IgM antibodies towards CP increased significantly by both routes of immunization with viable bacteria. The anti-CP activity of all three isotypes in sera and BALF was low in all groups compared with the positive controls, although inoculation of viable A. pleuropneumoniae led to higher levels of antibody concentration than inactivated bacteria. Our results indicate a traffic of primed lymphocytes from the gut into the bronchoalveolar airways and further support the hypothesis that polysaccharide-specific B cells may functionally mature at the mucosal surfaces.


Subject(s)
Actinobacillus pleuropneumoniae/immunology , Antibodies, Bacterial/biosynthesis , Antigens, Bacterial/immunology , Bronchoalveolar Lavage Fluid/immunology , Lung/immunology , Polysaccharides, Bacterial/immunology , Administration, Oral , Aerosols , Animals , Antigens, Bacterial/administration & dosage , Immunoglobulin Isotypes/immunology , Male , Swine
7.
Berl Munch Tierarztl Wochenschr ; 106(10): 330-3, 1993 Oct.
Article in German | MEDLINE | ID: mdl-8250824

ABSTRACT

In pigs coming from fattening units with tenacious pneumonitis problems the attempt was made to find an etiological diagnosis in living pigs by bronchoalveolar lavage (BAL) and serological examinations on antibodies against Mycoplasma hyopneumonia, Actinobacillus pleuropneumoniae and Influenza-A-virus (serotypes H1N1 and H3N2). In some cases the results of the bacteriological examinations of the BAL were compared with the post mortem findings. Both methods yield similar results. Mycoplasma hyopneumonia could neither be cultured from the BAL nor indicated the results of the serological examinations infections with M. hyopneumoniae. Pasteurella multocida was isolated from 73% of the BAL-samples. Actinobacillus pleuropneumoniae was found in 4 from 90 samples. Positive antibody titers against Influenza-virus in most of the sera indicate that the clinical course of Influenza is changing from an acute epidemic to an enzootic disease in fattening units.


Subject(s)
Bronchoalveolar Lavage Fluid/microbiology , Pneumonia/veterinary , Swine Diseases/diagnosis , Animals , Antibodies, Bacterial/blood , Antibodies, Viral/blood , Bronchoscopy/veterinary , Lung/microbiology , Pneumonia/diagnosis , Swine
8.
Dtsch Tierarztl Wochenschr ; 96(7): 371-3, 1989.
Article in German | MEDLINE | ID: mdl-2776673

ABSTRACT

By means of cultural examination, coagglutination test (CT) and indirect fluorescent-antibody-technique (IFAT) a total of 199 lung specimens from necropsy pigs from Northwestern Germany with symptoms of pleuropneumonia was examined for Actinobacillus (Haemophilus) pleuropneumoniae (AP). The CT was used to detect type specific antigens in lung extracts and the IFAT was performed on tissue sections. Both tests were found to be specific. Detection and identification of AP by either test were successful in 68 of 199 lung specimens. AP was isolated out of 40 lungs, antigen detection by CT was successful in 40 and by IFAT in 65 lung samples. In 26.5% of the positive samples AP was demonstrated only by IFAT. In 4.4% of the positive specimens AP was demonstrated only by cultural examination, but the detected serovars were not accounted in IFAT and CT. In 44.1% of the positive specimens AP was isolated or detected by all three techniques. The predominating serovar was serovar 9 followed by 2 and 7. One field isolate could be identified as serovar 3 and another one as serovar 10. Furthermore one isolate was untypable. IFAT and CT were limited for detection of serovars 2, 7 and 9. Detection of multiple serovars in few lung samples was successful only by IFAT. Indirect fluorescent-antibody-technique was found to be more sensitive than coagglutination test and cultural examination. On the other hand CT was found to be less time consuming and easier to evaluate than other tests. By this, coagglutination test seems to be preferable in examining large numbers of lung samples.


Subject(s)
Actinobacillus Infections/veterinary , Actinobacillus/isolation & purification , Lung/microbiology , Pneumonia/veterinary , Swine Diseases/microbiology , Actinobacillus Infections/microbiology , Animals , Haemophilus/isolation & purification , Haemophilus Infections/microbiology , Haemophilus Infections/veterinary , Pneumonia/microbiology , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...